Clinical Trial Update: Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update examining ticagrelor in combination with aspirin to prevent cardiovascular events after coronary artery bypass grafting; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)
• BRILINTA (ticagrelor)

Snippet

Sponsor: Cardiology Research UBC | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED